Circulating tumor cells in advanced non-small cell lung cancer patients are associated with worse tumor response to checkpoint inhibitors
Menno Tamminga, Sanne de Wit, T. Jeroen N. Hiltermann, Wim Timens, Ed Schuuring, Leon W. M. M. Terstappen, Harry J. M. Groen
Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 173; DOI: 10.1186/s40425-019-0649-2